AVNT Veranta Price Prediction: 5th of October
1 extracted signal · 0 resolved · 1 still active
C-Zar Gets Crypto Independent analyst profile- Source published
- 05 Oct 2026, 13:30 UTC
- Recorded by Tahlil Plus
- 05 Oct 2026, 14:33 UTC
AI-generated source summary
The analysis focuses on the AVNTUSDT cryptocurrency pair on a weekly timeframe, observing a long-term downtrend from its all-time high. The current price is noted around $0.1333. The speaker identifies a potential rounded bottom pattern forming, suggesting a shift in momentum. The volume has been decreasing during the downtrend and is now showing signs of picking up. The key observation is the potential for a significant upward movement, with targets inferred to be around the $0.6500 level, aligning with Fibonacci extensions. The fail bound, invalidating the bullish outlook, is conservatively set below the current consolidation area, around $0.07. The indicators suggest bullish momentum building, with MACD and RSI showing positive signs. The overall thesis is that AVNTUSDT is at a critical juncture, poised for a substantial recovery move towards higher price levels, driven by a shift in market sentiment and technical indicators.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
C-Zar Gets Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.